...need is for the manufacturing to work.” Brad Bolzon, Versant In 2015, Celyad S.A. and Medisun International Ltd....
...Academia Japan Inc., Kyoto, Japan Juno Therapeutics Inc. (NASDAQ:JUNO), Seattle, Wash. Kyoto University, Kyoto, Japan Medisun International Ltd....

...Inc. (NASDAQ:CLVS) Rociletinib NSCLC FDA panel; PDUFA date 4/12/16; 6/28/16 Celyad S.A. (Euronext:CYAD; NASDAQ:CYAD) / Medisun International Ltd....

...rindopepimut EGFRvIII-positive newly diagnosed glioblastoma Final Ph III data YE16 Celyad S.A. (Euronext:CYAD; NASDAQ:CYAD) / Medisun International Ltd....

...companies did not respond to inquiries (see BioCentury, April 13). Celyad S.A. (Euronext:CYAD;NASDAQ:CYAD), Mont-Saint-Guibert, Belgium Medisun International Ltd....

...Raised: EUR12.5 million ($17.1 million) Shares: 284,090 Price: EUR44 Shares after offering: 7 million Investor: Medisun International Ltd....

...at €44 in the second tranche of a €25 million ($34 million) private placement to Medisun International Ltd....

...44 in the second tranche of a EUR 25 million ($34 million) private placement to Medisun International Ltd....

...patient’s heart via Cardio3’s C-Cath intra-myocardial delivery catheter. Cardio3 BioSciences S.A . (Euronext:CARD), Mont-Saint-Guibert, Belgium Medisun International Ltd....